Abstract
The fungal transformations of medroxyrogesterone (1) were investigated for the first time using Cunninghamella elegans, Trichothecium roseum, and Mucor plumbeus. The metabolites obtained are as following: 6 beta, 20-dihydroxymedroxyprogesterone (2), 12 beta-hydroxymedroxyprogesterone (3), 6 beta, 11 beta-dihydroxymedroxyprogesterone (4), 16 beta-hydroxymedroxyprogesterone (5), 11 alpha, 17-dihydroxy-6 alpha-methylpregn-4-ene-3, 20-dione (6), 11-oxomedroxyprogesterone (7), 6 alpha-methyl-17 alpha-hydroxypregn-1,4-diene-3,20-dione (8), and 6 beta-hydroxymedroxyprogesterone (9), 15 beta-hydroxymedroxyprogesterone (10), 6 alpha-methyl-17 alpha, 11 beta-dihydroxy-5 alpha-pregnan-3, 20dione (11), 11 beta-hydroxymedroxyprogesterone (12), and 11 alpha, 20-dihydroxymedroxyprogesterone (13). Among all the microbial transformed products, the newly isolated biotransformed product 13 showed the most potent activity against proliferation of SH-SY5Y cells. Compounds 12, 5, 6, 9, 11, and 3 (in descending order of activity) also showed some extent of activity against SH-SY5Y tumour cell line. The never been reported biotransformed product, 2, showed the most potent inhibitory activity against acetylcholinesterase. Molecular modelling studies were carried out to understand the observed experimental activities, and also to obtain more information on the binding mode and the interactions between the biotransformed products, and enzyme.